Eli Lilly and Incyte’s arthritis drug baricitinib helped reduce the risk of death in hospitalised COVID-19 patients by 13% regardless of which other coronavirus treatment they were given, according to a large British study. Over 8,000 patients were administered baricitinib in addition to usual care, at random, or usual care alone, as part of the so-called RECOVERY trial, scientists from …
Read More »BARICITINIB: DRUG REDUCES RISK OF COVID DEATH IN LARGE UK TRIAL
March 5, 2022